Post-hoc analysis of real-world retrospective study on neoadjuvant chemotherapy combined with immunotherapy for stage I-III non-small cell lung cancer

Background and purposeReal-world data on neoadjuvant therapy for stage I-III non-small cell lung cancer (NSCLC) is limited. This study evaluates the efficacy and safety of neoadjuvant chemotherapy alone versus chemotherapy combined with immunotherapy, focusing on pathological response, imaging outco...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Yanchi Shao, Shenghan Wang, Yingchun Yu, Weiwei Yang, Lei Song, Wuyuntanghesi, Yanbin Zhao
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Frontiers Media S.A. 2026-01-01
Цуврал:	Frontiers in Immunology
Нөхцлүүд:	NSCLC NLR PLR SII PNI prognosis
Онлайн хандалт:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1576951/full
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!